[1]
M. Mohammed and N. Omar, “Assessment of Liver Fibrosis after Direct-Acting Antiviral Therapy in Compensated and Decompensated HCV-related Liver Disease”, ijirms, vol. 4, no. 04, p. 256 to 263, Apr. 2019.